NACA said readiness assessments have been completed in 10 states, including Lagos, Kano, Akwa Ibom and Anambra.

Vaccine development remains central to reducing incident HIV globally, particularly where long-acting PrEP access is limited, ...

NACA said readiness assessments have been completed in 10 states, including Lagos, Kano, Akwa Ibom and Anambra.Nigeria is preparing to introduce lenacapavir, a new twice-yearly injectable drug for HIV ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of new Phase 3 ARTISTRY-1 and ARTISTRY-2 trial data at ...

Long-acting antiviral medications are transforming HIV prevention and care, requiring only minimalistic dosing. But as the use of lenacapavir expands, scientists are probing a critical question: If ...

The federal government has announced that a new drug for HIV prevention, Lenacapavir, will arrive in Nigeria in March 2026.

Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the ...

Zimbabwe's health authorities began administering the long-acting HIV prevention drug lenacapavir, making the country one of ...

Samson Mutua, 27, is the first Kenyan to receive Lenacapavir, a long-acting HIV prevention injection, marking a significant ...

Zimbabwe, where HIV has led to tens of thousands of deaths over the past two decades, is one of the first countries to roll out lenacapavir, a long-acting drug that authorities hope will slow new ...

The gutting of HIV drug programs isn't just bad policy; it threatens a repeat of history's deadliest mistake, writes .